Will the ACCC let IAG buy Wesfarmers Insurance?

The opportunity to swallow up a competitor would be appealing to IAG.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Market murmurings that conglomerate Wesfarmers (ASX: WES) will offload its Insurance division are getting louder with the Australian Financial Review not only reporting that recent talks between  global insurer Zurich Insurance and Wesfarmers have broken down but also that leading domestic insurer Insurance Australia Group (ASX: IAG) is considering making a $2 billion offer for the division.

The Wesfarmers Insurance division recorded earnings before interest and tax of $205 million in the 12 months to 30 June 2013 on revenue of nearly $2.1 billion. According to the AFR, should IAG purchase the division, IAG would move past QBE Insurance (ASX: QBE) to become the largest commercial underwriter in Australia, accounting for around 21% of the market.

A combined IAG-Wesfarmers Insurance would also have around 38% of the motor vehicle underwriting market, which some analysts are speculating would attract the attention of the Australian Competition and Consumer Commission (ACCC). One solution could be for IAG to jointly bid for Wesfarmers with another insurer such as Suncorp (ASX: SUN) and let the partner take the motor insurance business so as to not raise ACCC concerns, however this would presumably not be a particularly desirable outcome for IAG.

Foolish takeaway

For Wesfarmers shareholders, the opportunity to sell the sub-scale, non-core insurance business and utilise the sales proceeds for more shareholder value enhancing opportunities is highly appealing.

Likewise for IAG shareholders, the opportunity to swallow up a competitor in what would be akin to a bolt-on acquisition is highly appealing given the synergies it would create including the benefits of scale and leveraging the fixed cost base across a wider revenue stream.

However, as investors in companies including McMillan Shakespeare (ASX: MMS) and GrainCorp (ASX: GNC) have seen recently, betting on regulatory outcomes is fraught with unknowns. For this reason while IAG would no doubt benefit from a purchase of Wesfarmers Insurance, investors trying to second guess whether the ACCC would allow the acquisition to proceed is complex and risky.

Motley Fool contributor Tim McArthur owns shares in QBE Insurance and McMillan Shakespeare.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »